UPDATE : Wednesday, June 26, 2019
상단여백
Why people still ask if AIDS is preventable by Kim Yun-mi 2019-06-26 17:02
Expat students exempted from mandatory health insurance enrollment, for now by Lee Han-soo 2019-06-26 15:32
Severance finds new gingival fibromatosis diagnostic biomarker by Lee Han-soo 2019-06-26 15:31
Voluntary nullifications of drug license tripled in H1 by Lee Hye-seon 2019-06-26 14:25
Seoul Pharma to export erectile dysfunction treatment to Azerbaijan by Lee Han-soo 2019-06-26 13:58
라인
Patients with ‘Invossa stigma’ struggle to get treatment, insurance by Jeong Sae-im 2019-06-26 13:22
Novartis’ Tasigna confirms long-term success for chronic myelogenous leukemia by Lee Han-soo 2019-06-26 11:39
Huons Global launches new BTX in Korea by Lee Han-soo 2019-06-26 10:52
Hanmi, Sanofi revise accord on co-developing diabetes drug by Lee Han-soo 2019-06-25 17:36
‘Imbruvica raised survival rate of mantle cell lymphoma patients’ by Kim Yun-mi 2019-06-25 15:34
라인
CHA Biotech to transfer SCRMI’s shares, technology to AIRM by Lee Han-soo 2019-06-25 15:25
Oscotech wins exception policy for continued R&D for new drugs by Jeong Sae-im 2019-06-25 14:11
Regulator OKs P3 trial for Eisai's Alzheimer treatment by Lee Han-soo 2019-06-25 14:09
Novartis’ Cosentyx shows durable, comprehensive treatment for psoriatic disease by Lee Han-soo 2019-06-25 14:09
Celltrion denies delay in local license application for HIV drug Temixys by Lee Hye-seon 2019-06-25 10:56
라인
'Elderly patients with atrial fibrillation have higher risk of dementia' by Lee Han-soo 2019-06-24 15:50
Latecomer experimental drug no better than Dupixent in trial by Kim Yun-mi 2019-06-24 15:49
Daewoong wins new indications for Nabota by Lee Han-soo 2019-06-24 14:47
‘Expensive immunotherapies are not cure-all’ by Park Gi-taek 2019-06-24 14:46
Kang Stem Biotech completes P3 trials for stem cell-based atopy treatment by Lee Han-soo 2019-06-24 12:19
여백
여백
여백
Back to Top